Published in Naunyn Schmiedebergs Arch Exp Pathol Pharmakol on January 01, 1968
The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Pharmacol Rev (1971) 2.78
Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89
The essential tyrosine of the internalization signal in lysosomal acid phosphatase is part of a beta turn. Cell (1991) 1.72
Characterization of the binding interface between ubiquitin and class I human ubiquitin-conjugating enzyme 2b by multidimensional heteronuclear NMR spectroscopy in solution. J Mol Biol (1999) 1.25
[Fluorometric determination of microamounts of calcium in muscle]. Experientia (1966) 1.25
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem (2000) 1.25
Kinetic analysis of four HIV-1 reverse transcriptase enzymes mutated in the primer grip region of p66. Implications for DNA synthesis and dimerization. J Biol Chem (1997) 1.12
Evidence for two different Na+-dependent [3H]-ouabain binding sites of a Na+-K+-ATPase of guinea-pig hearts. Br J Pharmacol (1977) 1.09
The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J Mol Biol (1993) 1.06
Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil. J Cardiovasc Pharmacol (2001) 1.00
A simple preparation technique for a microsomal Maplus-K-plus-activated ATPase from cardiac tissues of different species. Prep Biochem (1974) 0.97
Increase in suicidal thoughts and tendencies. Association with diazepam therapy. JAMA (1968) 0.96
[Strophanthin action on myocardial oxygen consumption in dependence upon the functional capacity of the heart]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.96
Influence of cardiac glycosides on calcium binding in muscle subcellular components. J Pharmacol Exp Ther (1969) 0.95
Pre-steady-state kinetic characterization of RNA-primed initiation of transcription by HIV-1 reverse transcriptase and analysis of the transition to a processive DNA-primed polymerization mode. Biochemistry (1998) 0.95
Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension (2001) 0.95
Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation (1993) 0.95
Ocular concentrations of mitomycin C using different delivery devices. Ophthalmologica (1998) 0.94
Effects of different inotropes with antioxidant properties on acute regional myocardial ischemia in isolated rabbit hearts. Gen Pharmacol (1995) 0.94
Treatment of hepatic coma with exchange transfusion and peritoneal dialysis. JAMA (1967) 0.93
[On the intracellular distribution of 3H-digitoxin in the guinea pig heart]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.92
Automation of NMR measurements and data evaluation for systematically screening interactions of small molecules with target proteins. J Biomol NMR (2000) 0.88
Proton nuclear magnetic resonance assignments and secondary structure determination of the ColE1 rop (rom) protein. Biochemistry (1990) 0.88
Adverse reactions with calcium antagonists. Hypertension (1983) 0.87
Intensive dynamic back exercises with or without hyperextension in chronic back pain after surgery for lumbar disc protrusion. A clinical trial. Spine (Phila Pa 1976) (1993) 0.86
Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.86
Simultaneous measurement of intracellular Ca(2+) and nitric oxide: a new method. Cell Calcium (2000) 0.86
Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts. Am J Transplant (2014) 0.85
Actions of prostaglandin E2 on myocardial mechanics, coronary vascular resistance and oxygen consumption in the guinea-pig isolated heat preparation. Br J Pharmacol (1975) 0.85
Nitric oxide causes a cGMP-independent intracellular calcium rise in porcine endothelial cells-a paradox? Microvasc Res (2000) 0.85
A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.85
Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro. Eur J Pharmacol (1980) 0.84
Platelet induced aggravation of acute ischaemia in an isolated rabbit heart model. Cardiovasc Res (1987) 0.84
Functional and antiischemic effects of luteolin-7-glucoside in isolated rabbit hearts. Gen Pharmacol (1994) 0.83
Functional effects of adrenochrome in isolated rabbit heart. Pharmacol Toxicol (1995) 0.83
Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase. Br J Pharmacol (1987) 0.83
Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase. Biochemistry (1998) 0.83
Backbone resonance assignment of the N-terminal 24 kDa fragment of the gyrase B subunit from S. aureus complexed with novobiocin. J Biomol NMR (2000) 0.82
Prearrhythmia: changes preceding arrhythmia, new aspects by epicardial mapping. Basic Res Cardiol (1990) 0.82
Increase in the coronary vascular resistance by indomethacin in the isolated guinea pig heart preparation in the absence of changes in mechanical performance and oxygen consumption. Eur J Pharmacol (1976) 0.82
The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis. Transplant Proc (2006) 0.82
Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.82
The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis. J Cardiovasc Pharmacol (1984) 0.81
Caffeine in saliva after peroral intake: early sample collection as a possible source of error. Ther Drug Monit (1997) 0.81
Sodium-dependent cardiac glycoside binding: experimental evidence and hypothesis. Br J Pharmacol (1978) 0.81
Heat production and oxygen consumption of the isolated rabbit heart: their relation to mechanical function. Basic Res Cardiol (1977) 0.81
Determination of the solution structure of the SH3 domain of human p56 Lck tyrosine kinase. J Biomol NMR (1996) 0.81
Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol (1997) 0.81
A new method for analysing the geometry and timecourse of epicardial potential spreading. Int J Biomed Comput (1988) 0.81
Activin A and activin receptors in thyroid cancer. Thyroid (2001) 0.81
Effect of amrinone and milrinone on myocardial ischemia extent and infarct size in isolated rabbit hearts. Arzneimittelforschung (1993) 0.81
Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function. Am J Transplant (2013) 0.80
Reduced responses of nitrendipine in PGF2 alpha-precontracted porcine isolated arteries after pretreatment with methylene blue. Basic Res Cardiol (1991) 0.80
The contribution of neutrophils to reperfusion arrhythmias and a possible role for antiadhesive pharmacological substances. Cardiovasc Res (1995) 0.80
Cardioprotection by superoxide dismutase: a catecholamine-dependent process? Anesth Analg (1993) 0.80
[Liability of different cardenolides on papillary muscle and on microsomal ATPase of guinea pig hearts]. Naunyn Schmiedebergs Arch Pharmakol (1971) 0.80
Intervascular and stimulus selectivity of nitrendipine and related derivatives in KCl and prostaglandin F2 alpha precontracted porcine arteries. Br J Pharmacol (1992) 0.79
Reduced transcoronary exchange and prostaglandin synthesis in diabetic rat heart. Am J Physiol (1984) 0.79
The action of different coronary active drugs on intra- and extravascular components of local myocardial perfusion. Basic Res Cardiol (1981) 0.79
Local myocardial perfusion and epicardial NADH-fluorescence after coronary artery ligation in the isolated guinea pig heart. Basic Res Cardiol (1984) 0.79
[Comparison of the subcellular distribution of 3H-strophanthin and 3H-digitoxin in guinea pig hearts]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.79
Endothelial function and contractility of human vena saphena magna prepared for aortocoronary bypass grafting. Thorac Cardiovasc Surg (1991) 0.79
The bradykinin-induced coronary vasodilation. Evidence for an additional prostacyclin-independent mechanism. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.79
The influence of 3-ester side chain variation on the cardiovascular profile of nitrendipine in porcine isolated trabeculae and coronary arteries. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.79
Beneficial effect of amrinone on the size of acute regional ischemia in isolated rabbit hearts. J Cardiothorac Vasc Anesth (1993) 0.79
[Dissociation of function and metabolism of the isolated guinea pig heart under the influence of phosphodiesterase inhibitors]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.79
Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity. Drug Metab Dispos (1980) 0.79
Halide dependence of the halorhodopsin photocycle as measured by time-resolved infrared spectra. Biophys J (2001) 0.78
Sensitive and convenient high-performance liquid chromatographic method for the determination of mitomycin C in human plasma. J Chromatogr B Biomed Sci Appl (1997) 0.78
A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Am J Respir Crit Care Med (1997) 0.78
Response to histamine of the intact coronary system in an isolated rabbit heart preparation. Eur Heart J (1989) 0.78
Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.78
Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide. Drugs (1999) 0.78
Different sensitivities of arteries and veins to glyceryltrinitrate-induced relaxation and tolerance: an "in vitro" study on isolated vessels from rabbits. Arch Int Pharmacodyn Ther (1987) 0.78
Free radical scavenging properties of beta-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.78
Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries. Basic Res Cardiol (1993) 0.78
[Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. Klin Wochenschr (1985) 0.78
Novel halogenated dihydropyridine derivatives with high vascular selectivity. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.77
Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds. J Cardiovasc Pharmacol (1995) 0.77
Celiprolol exerts microvascular dilatation by activation of beta 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.77
Differential effects of pharmacological HIF preconditioning of donors versus recipients in rat cardiac allografts. Am J Transplant (2013) 0.77
[Reversibility of the effect of digitoxin, strophanthidine and strophanthidine-3-bromoacetate on the papillary muscle and a microsomal Na+-K+-activated ATPase of the guinea pig]. Experientia (1969) 0.77
The potential of epicardial activation mapping in isolated hearts for the assessment of arrhythmogenic and antiarrhythmic drug activity. J Pharmacol Methods (1989) 0.77
Nifedipine antagonizes ouabain-induced ST-segment changes and derangement of epicardial activation pattern in isolated rabbit hearts. Int J Cardiol (1990) 0.77
The influence of reduced serum potassium level on the toxicity of some cardenolides in guinea pigs. Basic Res Cardiol (1981) 0.77
The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process. Thromb Haemost (1994) 0.77
Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes. Planta Med (1999) 0.77
Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts. Transpl Int (1996) 0.76
Deleterious effect of exogenous angiotensin-I on the extent of regional ischaemia and its inhibition by captopril. Eur Heart J (1993) 0.76
Comparative studies of the influence of various K+ concentration on the action of K-strophthidin, digitoxin and strophanthidin-3-bromoacetate on papillary muscle and on membrane-ATPSA of guinea pig hearts. Eur J Pharmacol (1971) 0.76
Nisoldipine increases the bioavailability of endothelial NO. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.76
The effect of the calcium-antagonist nitrendipine on intracellular calcium concentration in endothelial cells. Br J Pharmacol (1996) 0.76
A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol (1994) 0.76
Influence of (-)-S-Bay K 8644, (+/-)-Bay W 5035 and (+/-)-Bay T 5006 on hemodynamics and FITC-dextran 3 elution kinetics in isolated rat hearts. Gen Pharmacol (1993) 0.76
Switched single-electrode voltage-clamp amplifiers allow precise measurement of gap junction conductance. Am J Physiol (1999) 0.76
[The effect of strophanthidin-3-bromacetate on the papillary muscle of guinea pig hearts]. Naunyn Schmiedebergs Arch Pharmakol (1971) 0.76
Differences in the potassium dependence of the myocardial action of some semisynthetic cardiotonic steroids. Adv Myocardiol (1980) 0.76